뉴스
- Remedi Surges 23%; Bio Solution Climbs on China Expansion [K-bio pulse] Portable X-ray maker Remedi saw its shares surge after reporting explosive earnings growth. The company is expanding rapidly not only in South Korea but also ov
- Onconic Surges on Jaqbo’s India Approval[K-Bio Pulse] South Korea’s pharmaceutical and life sciences sectors advanced in tandem on Aug. 6, led by Onconic Therapeutics, Qurient and Voronoi.The pharmaceutical i
- Kosdaq Bio Rally...Alteogen Soars on European Patent Win [K-bio Pulse] On July 23, the domestic stock market surged as artificial intelligence (AI) investment expectations combined with strong momentum in healthcare and biotechnolo
- Broker Call Lifts Qurient, AbClon, L&C Bio Rebounds on Rights Offering[K-Bio Pulse] South Korea's Kosdaq market closed higher on Tuesday, supported by net buying from foreign and institutional investors, while most pharmaceutical and biotechnol
- Curiox Hits Limit-Up; CPS Overhang Weighs on OliX[K-Bio Pulse] On Aug. 14, Curiox Biosystems hit the daily upper limit after announcing a “multi-unit” order from a global pharmaceutical company. OliX Pharmaceuti
- FromBio Hits Limit-Up as Trading Resumes; Curacle Surges on Follow-On Licensing Hopes [K-Bio Puls... On Aug. 10, South Korean pharmaceutical and biotech stocks broadly advanced as the KOSDAQ rebounded. FromBio soared to the daily upper limit as trading resumed
- Deepnoid and Peptron Hit Daily Limit, L&C Bio Falls on Rights Offering[K-Bio Pulse] South Korea's pharmaceutical and biotechnology sector received a boost on Aug. 3 as the KOSDAQ market posted strong gains. Buying momentum intensified, triggeri
- Korean Dental Stocks Rally on M&A, Strong Earnings[K-Bio Pulse] Shares of dental-related companies rallied in South Korea's pharmaceutical, biotech and health care market on Aug. 11, buoyed by expectations for business expan
- JW Pharma Jumps 15%, OliX Sinks 14% on Overhang Concerns[K-Bio Pulse] South Korean pharmaceutical and biotech stocks broadly traded lower, with JW Pharmaceutical and OliX Pharmaceuticals drawing particular attention. JW Pharmaceut
- Kolon crashes on TG-C failure; NGeneBio soars [K-bio pulse] Shares of three Kolon Group affiliates tumbled Tuesday after Kolon TissueGene's osteoarthritis cell and gene therapy TG-C — formerly known as Invossa &mda
1 페이지
다음 →